Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureMisaki Kinoshita-Ise, Manabu Ohyama
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Blockade of IL-7 signaling suppresses inflammatory responses and reverses alopecia areata in C3H/HeJ mice
10.1126/sciadv.abd1866 · 2021
Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
10.3389/fimmu.2025.1681163 · 2025
Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the Allegro clinical development programme
10.1111/jdv.20547 · 2025
Two phase 3 trials of baricitinib for alopecia areata
10.1056/nejmoa2110343 · 2022
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
10.1016/j.jaad.2024.06.097 · 2024
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial
10.1016/s0140-6736(23)00222-2 · 2023
New insights into the regulation of T cells by gamma(c) family cytokines
10.1038/nri2580 · 2009
Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model [e-pub ahead of print]
10.1016/j.jid.2026.05.028 · 2026
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
10.1038/nm.3645 · 2014
No additional external references are available.